• Search
  • Helpdesk
  • Sales contact

Immunology Case Study

Last updated: May 6, 2025

Immunology studies present specific challenges: their eCOA build can be complex, site staff must play a key role, and study duration can be very long whilst patients are in pain.

To overcome these challenges, Kayentis offers strong and global experience in immuno-inflammation trials, especially with:

  • experienced teams and a powerful solution to face eCOA complexities,
  • adapted options to support site staff,
  • and additional features for the comfort of the patient

Therefore, Kayentis contributes to the success and quality of immunology clinical trials.

Learn more in the case study 👇

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

Rethinking Phase 1 Oncology Trials with Electronic Patient-Reported Outcomes

November 4 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
The primary aim of Phase 1 oncology clinical trials is to determine the safety of a new treatment, and to...